Both companies aim to improve the efficiency and success rate of the current drug discovery process.
It is designed to tackle mental health issues
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
The competition received over 42 entries from nursing colleges across Maharashtra
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Subscribe To Our Newsletter & Stay Updated
